[18F]PI-2620 Phase 3 Histopathological Study
NCT05641688
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
[18F]PI-2620
Sponsor
Life Molecular Imaging Ltd